在多种人群中获得临床试验
Tareefe Montaque1, John Stewart1
1Department of Surgery, Morehouse School of Medicine, Atlanta, Georgia, USA.
Journal of surgical oncology
|November 26, 2024
概括
少数群体由于不信任和障碍,在癌症临床试验中的参与率很低. 改善接入需要实用性试验,患者导航,财政援助和多元化的医疗人员,以获得公平的结果.
科学领域:
- 在瘤学瘤学.
- 健康 公平 卫生 公平
- 临床研究 临床研究
背景情况:
- 癌症不成比例地影响少数群体.
- 少数群体在瘤临床试验中的参与率显著低.
- 关键的因素包括历史的不信任,系统障碍和医疗系统内隐含的偏见.
研究的目的:
- 确定和解决少数群体在癌症临床试验中的代表性不足问题.
- 探索加强瘤学研究的获取和多样性的策略.
- 促进公平的医疗保健服务和改善所有人群的研究成果.
主要方法:
- 对临床试验参与障碍的现有文献的审查.
- 分析旨在改善少数民族入学率的当前战略.
- 确定包容性临床试验设计和实施的最佳实践.
主要成果:
- 不信任,结构性障碍和隐性偏见是少数群体参与率低的主要原因.
- 实用性试验设计可以提高可访问性.
- 患者导航,财政援助和多元化的医疗保健专业人员是有效的干预措施.
结论:
- 解决癌症临床试验参与方面的差异对于健康公平至关重要.
- 实施有针对性的战略可以显著提高少数群体的代表性.
- 提高临床研究的多样性,可以为代表性不足的人群带来更好的健康结果.
更多相关视频
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.2K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91
